Cigna: I'm Buying What Others Are Ignoring
Are Wall Street Analysts Bullish on Cigna Group Stock?
Cigna (CI) Stock Still Looks Cheap Following Raised 2026 Outlook
Cigna Group (CI) Reports Q2 Earnings And Buybacks, Is It Trading At A Discount?
Jefferies downgrades Cigna to Hold on mounting 2027 earnings headwinds
Raymond James Downgrades Cigna Group (CI)
Jefferies Downgrades Cigna Group (CI)
Jefferies Downgrades Cigna Group to Hold, Lowers Price Target to $307
Raymond James cuts Cigna to Outperform on lack of near-term catalysts
Raymond James Downgrades Cigna Group to Outperform, Lowers Price Target to $320
Cigna's Valuation Gap Still Stands Out
Wells Fargo Maintains Equal-Weight on Cigna Group, Raises Price Target to $307
Guggenheim Maintains Buy on Cigna Group, Raises Price Target to $361
Is Stronger Q2 Earnings And Outlook Revision Altering The Investment Case For Cigna Group (CI)?
Barclays Maintains Equal-Weight on Cigna Group, Raises Price Target to $310
Cigna Group Q2 Earnings Call Highlights
The Cigna Group (CI) (Q2 2026) Earnings Call Highlights: Strong Performance Drives Raised ...
CI Q2 Earnings Beat Estimates on Cigna Healthcare Strength
Cigna (CI) Reports Q2 Earnings: What Key Metrics Have to Say
Cigna Expects Lower Growth in Popular GLP-1 Drug Prescriptions
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.